Eli Lilly has launched a new biotech incubator in San Diego, Gateway Labs, offering collaborative lab and office spaces with access to expertise aiming to foster innovation. The location spans over 82,000 square feet and already houses several early-stage biotechs and more than 250 employees. This expansion reflects Lilly's commitment to nurturing biotech collaboration and accelerating therapeutic development by bridging academia, startups, and big pharma capabilities, with plans to open other sites globally.